ArticleFrontiers in immunology2026
Machine learning-based identification of concomitant stroke and prognostic analysis in patients with Guillain-Barré syndrome: a retrospective study.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Guillain-Barré syndrome (GBS) constitutes an immune-mediated inflammatory polyradiculoneuropathy. Stroke may coexist with GBS during the same clinical episode, but the associated clinical predictors remain insufficiently characterized. The present investigation therefore sought to construct a machine learning-based model for identifying concomitant stroke in patients with GBS. Methods: This retrospective cohort study included 260 patients with GBS who received care at the Second Affiliated Hospital of Army Medical University from January 1, 2015, to December 31, 2024. All candidate predictors were collected at admission. Feature selection was conducted using LASSO regression, and seven machine learning algorithms were developed and compared. An independent external validation cohort of 60 patients was obtained from the First Affiliated Hospital during the same period. Patients were subsequently grouped according to model-estimated probabilities, and short-term functional outcomes were compared between groups. Results: Nine clinical predictors were selected to construct seven machine learning models. The neural network architecture exhibited the best performance for identifying concomitant stroke. Internal validation yielded an AUROC of 0.838 (95% CI: 0.739-0.923) for the optimal model. Sensitivity analysis excluding patients with documented prior stroke showed comparable performance. For all outcome measures, time displayed a substantial primary impact (p < 0.001), while interactive terms stayed statistically non-significant (p > 0.05). Conclusion: The ANN model showed good performance for admission-time identification of concomitant stroke in patients with GBS and distinguished clinically different functional profiles among model-defined groups. Notably, while the longitudinal interaction between temporal factors and assigned risk strata did not achieve statistical significance, the stratification methodology successfully discerned clinically distinct outcome profiles in GBS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.